It is especially difficult within the life sciences sector – and indeed everyday life – to avoid mentions of AI and the inevitable changes it will bring, and is bringing, to drug discovery. Further difficulty stems from the need to distinguish between hype, reality and fantasy. Drug discovery and… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a cancer drug demonstrated it could reduce tumours by as much as… Read More
News round-up for 1 June – 5 June by Bruno Quinney, Content Team at DDW. This week, a cancer drug has demonstrated it could reduce tumours by as much as 55%. Elsewhere, AI has been a recurrent theme in both clinical trials and drug development. The top stories:… Read More
The use of AI in clinical trials is being held back by a lack of trust and regulatory uncertainty, professionals say. A poll from The Pistoia Alliance found that half of respondents agreed trust and regulatory uncertainty were barriers to AI adoption in clinical trials. … Read More
The use of artificial intelligence is widespread across life sciences organisations but its use in drug research and development is limited, analysis finds. Research by The Pistoia Alliance, a not-for-profit life sciences advocacy group, shows 30% of life sciences professionals say their organisation has implemented an enterprise-wide AI… Read More
Dr Patrick Courtney, Member of Board of Directors of SiLA, compares the uptake of automation in industries other than drug discovery. … Read More
The use of artificial intelligence (AI) continues to rise, according to the results of the Pistoia Alliance’s annual Lab of the Future survey. The results show that 77% of respondents expect to use AI in the next two years. It also remains the number one investment area… Read More
Resistance to change has emerged as the biggest barrier (51%) to data innovation in the pharmaceutical industry, while lack of skills is the second most cited barrier (17%). The new findings on data-driven innovation and AI in life sciences were released by the Pistoia Alliance in conjunction… Read More
The Pistoia Alliance has released the results of its annual Lab of the Future survey, conducted in partnership with Open Pharma Research. The survey of 200 experts spanning Europe, the Americas and APAC was presented at the Lab of the Future Congress in Amsterdam from 1-2 October 2024. … Read More
New survey findings have revealed that 77% of R&D professionals are not using in vitro cell-based alternatives to animal testing, and only 23% describe themselves as ‘very familiar’ with any kind of animal model alternative. More than 350 survey respondents participated in the survey by The… Read More
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced a new partnership with Matador Japan KK to enable pre-competitive collaboration in the Japanese market. The Alliance and Matador share the vision that bringing together experts from diverse backgrounds… Read More
The Pistoia Alliance Pharma Innovation Council has been launched, bringing together 13 leaders from large global pharmaceutical companies. The Council will explore common challenges at a grassroots level and seed ideas for new pre-competitive projects aligned with the Alliance’s strategic themes: Emerging Sciences and Technology, Improving the… Read More
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has expanded its popular Women in STEM Leadership Programme to include other underrepresented communities in a new 2023 initiative. The three-month programme brings together leaders from life science… Read More
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a pilot for its new Women in STEM leadership programme, which involves 15 large pharma companies that will support diversity in executive roles and advocate a fairer working culture… Read More
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) with the aim of harnessing real-world data (RWD) from social media. The organisation is calling on technology companies, data scientists and RWD experts to join… Read More
The Pistoia Alliance has appointed its first female President with Dr Becky Upton taking on the position, the organisation has announced. Dr Upton will lead the not-the-profit’s strategy with a focus on areas of increasing importance such as data standards, diversity and inclusion, sustainability and precision medicine. Read More
